Gujarat Themis (GUJTHEM) | Stock Overview & Key Data
Gujarat Themis Performance Comparison
Stock Range
Today's Range
Low: ₹357.90
High: ₹390.00
on August 20, 2025
52 Week Range
Low: ₹208.00
High: ₹405.00
on March 3, 2025
on August 1, 2025
All-Time High: ₹405.00 on August 1, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR39.6B
EPS
4.08
P/E Ratio (TTM)
88.96
Forward P/E
N/A
P/B Ratio
15.92
PEG Ratio
-2.82
Div. Yield
N/A
ROE
19.64%
Beta
-0.397
Debt to Equity
12.27
Financial Highlights
Profitability
Gross Margin
77.71%
Operating Margin
33.14%
Profit Margin
30.17%
Returns and Earnings
Return on Assets (TTM)
16.19%
Return on Equity (TTM)
19.64%
EBITDA
INR664.0M
Net Income (TTM)
INR446.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR13.57
Quarterly Revenue Growth (YoY)
-7.60%
Quarterly Earnings Growth (YoY)
-31.50%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis GUJTHEM | 39.63B Small-cap | 1.58% | 0.19% | 8.65% | 49.08% | 49.08% | 65.80% | 65.80% | 65.80% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 0.27% | -3.88% | -5.99% | -2.98% | -13.93% | -8.40% | 84.81% | 192.69% |
| Divi's Laboratories DIVISLAB | 1.64T Large-cap | 1.99% | -9.10% | -7.61% | 2.44% | 0.11% | 25.20% | 69.46% | 85.76% |
| Sun Pharma Advanced SPARC | 45.51B Small-cap | 4.19% | -8.09% | -11.48% | 12.35% | -26.33% | -34.00% | -36.71% | -22.67% |
| Aarti Drugs AARTIDRUGS | 44.80B Small-cap | 0.27% | -9.96% | 2.11% | 28.03% | 7.74% | -12.97% | 12.03% | -33.03% |
| Sequent Scientific SEQUENT | 43.92B Small-cap | 1.51% | -5.78% | -0.25% | 17.84% | -4.22% | 5.62% | 52.82% | 30.86% |
Ownership & Short Interest
Insider Ownership
71.88%
Institutional Ownership
1.15%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
93K
Average 90-Day Volume
207K
Gujarat Themis Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Gujarat Themis would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is GUJTHEM's 52-week high and low?
- In the last 52 weeks, Gujarat Themis reached a high of ₹405.00 (on August 1, 2025) and a low of ₹208.00 (on March 3, 2025).
- What is the market cap and P/E ratio for GUJTHEM?
- Curious about Gujarat Themis's size and valuation? Its market capitalization stands at 39.63B. When it comes to valuation, the P/E ratio (trailing twelve months) is 88.96, and the forward P/E (looking ahead) is N/A.
- Does GUJTHEM pay dividends? If so, what's the yield?
- As for dividends, Gujarat Themis isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Gujarat Themis's main competitors or similar companies to consider before investing?
When looking at Gujarat Themis, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -8.40% 84.81% Divi's Laboratories
DIVISLAB1.64T Healthcare Drug Manufacturers - Specialty & Generic 25.20% 69.46% Sun Pharma Advanced
SPARC45.51B Healthcare Drug Manufacturers - Specialty & Generic -34.00% -36.71% Aarti Drugs
AARTIDRUGS44.80B Healthcare Drug Manufacturers - Specialty & Generic -12.97% 12.03% Sequent Scientific
SEQUENT43.92B Healthcare Drug Manufacturers - Specialty & Generic 5.62% 52.82% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Gujarat Themis Biosyn Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Gujarat Themis's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 19.64%, the Debt to Equity ratio from the most recent quarter is 12.27, and its Gross Profit Margin stands at 77.71%.
- What is the recent revenue and earnings growth for GUJTHEM?
- Looking at Gujarat Themis's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by -7.60%, and quarterly earnings saw a YoY growth of -31.50%.
- How much of GUJTHEM stock is held by insiders and institutions?
- Wondering who owns Gujarat Themis stock? Company insiders (like executives and directors) hold about 71.88% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.15%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.